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Abstract
OBJECTIVE—We sought to identify hospital characteristics associated with community-
associated methicillin-resistant Staphylococcus aureus (CA-MRSA) carriage among inpatients.
DESIGN—Prospective cohort study.
SETTING—Orange County, California.
PARTICIPANTS—Thirty hospitals in a single county.
METHODS—We collected clinical MRSA isolates from inpatients in 30 of 31 hospitals in
Orange County, California, from October 2008 through April 2010. We characterized isolates by
spa typing to identify CA-MRSA strains. Using California’s mandatory hospitalization data set,
we identified hospital-level predictors of CA-MRSA isolation.
RESULTS—CA-MRSA strains represented 1,033 (46%) of 2,246 of MRSA isolates. By hospital,
the median percentage of CA-MRSA isolates was 46% (range, 14%–81%). In multivariate
models, CA-MRSA isolation was associated with smaller hospitals (odds ratio [OR], 0.97, or 3%
decreased odds of CA-MRSA isolation per 1,000 annual admissions; P < .001), hospitals with
more Medicaid-insured patients (OR, 1.2; P = .002), and hospitals with more patients with low
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comorbidity scores (OR, 1.3; P < .001). Results were similar when restricted to isolates from
patients with hospital-onset infection.
CONCLUSIONS—Among 30 hospitals, CA-MRSA comprised nearly half of MRSA isolates.
There was substantial variability in CA-MRSA penetration across hospitals, with more CA-MRSA
in smaller hospitals with healthier but socially disadvantaged patient populations. Additional
research is needed to determine whether infection control strategies can be successful in targeting
CA-MRSA influx.
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) was first
identified in the 1990s among healthy children and adults without healthcare exposure or
traditional risk factors for MRSA.1-3 In the past 2 decades, CA-MRSA prevalence has
steadily increased in the community and has become especially common in settings such as
gyms, the military, day care facilities, and schools and among high-risk populations, such as
injection drug users and men who have sex with men.4-6 CA-MRSA is genetically distinct
from healthcare-associated strains of MRSA (HA-MRSA), is typically susceptible to more
classes of antibiotics, and has historically caused less invasive disease, such as skin and soft-
tissue infections. However, there are increasing reports of CA-MRSA causing hospital-onset
disease in individual hospitals, which raises the possibility that CA-MRSA strains may
become widely endemic in hospitals in the near future.7-9
In the United States, the majority of CA-MRSA isolates consist of the pulsed-field gel
electrophoresis (PFGE) clone USA300 (analogous to spa type t008, multilocus sequence
type ST8). As USA300 emerges in healthcare settings, there is concern that this and other
CA-MRSA strains may cause more severe disease than community or HA-MRSA strains in
hospitalized patients. The ability of USA300 to cause severe disease may be attributable to
several distinguishing traits; USA300 carries a unique arginine catabolic element that may
confer increased fitness and expresses higher levels of virulence factors, such as Panton-
Valentine leukocidin and alphatoxin.10,11 In hospitals, USA300 has proven able to cause
invasive illness, including bloodstream infections,9 and case reports have newly identified
USA300 as a cause of rapidly progressive conditions, such as necrotizing pneumonia and
fasciitis.12,13 Furthermore, there is evidence that USA300 may be more transmissible
because of its greater fitness or higher growth rate.14,15 The potential for CA-MRSA strains
to cause more severe disease or lead to increased transmission makes the penetration of CA-
MRSA into healthcare settings of potential concern, although the few existing comparative
studies have yet to confirm increased severity of infection due to CA-MRSA.16,17
CA-MRSA penetration into hospitals has not been explored systematically or among a large
number of hospitals. It is currently unknown whether CA-MRSA is widely endemic, partly
because of inconsistent definitions of CA-MRSA based on onset of infection or antibiotic
susceptibility profile. Endemic CA-MRSA may lead to additional increases in MRSA
burden among hospitals, particularly if CA-MRSA proves to be more transmissible because
of greater fitness. Understanding factors associated with CA-MRSA penetration into
hospitals may inform infection control strategies targeting community sources. We collected
MRSA isolates from a county network of hospitals and identified hospital characteristics
associated with CA-MRSA isolation among inpatients.
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We conducted a prospective collection of clinical MRSA isolates from 30 of 31 hospitals in
Orange County, California, from October 2008 to April 2010. The remaining hospital was
small and did not participate, because it was closing. This study was approved by the
institutional review board of the University of California Regents. Because patient
identifying information was not collected, we did not obtain informed consent from patients
who provided MRSA samples.
Isolate Collection
Clinical (nonscreening) isolates of MRSA from unique patients were collected from hospital
microbiology laboratories. Hospitals were instructed to collect nonblood MRSA isolates
from consecutive unique patients up to a total of 100 or for a duration of 12 months,
whichever came first. Additionally, we collected up to 20 blood-derived isolates per month
from each hospital. Isolates from patients not admitted to the hospital (eg, emergency
department patients) were excluded from the study, as were screening isolates. Samples
were batched and delivered using soy agar slants to the Orange County Public Health
Laboratory. For repeated confirmation of MRSA, isolates were plated on selective media for
MRSA (BD CHROMagar). MRSA strains were stored at −65°C in 15% glycerol Brucella
broth.
Specimen Data and Hospital Characteristics
We collected the hospital day for onset of infection for each isolate. We defined hospital
onset (HO) as isolation 3 or more days after hospital admission and community onset (CO)
as isolation less than 3 days after hospital admission. We also collected the specimen source
(blood, wounds, sputum, urine, or other). Hospital characteristics were obtained from a
mandatory California hospital discharge data set18 and included annual admissions, hospital
type (acute care vs long-term acute care facility and pediatric vs adult), and the percentage
of patients at each hospital with the following characteristics: male sex, non-White race,
Hispanic ethnicity, Medicaid insurance, Medicare insurance, and Romano comorbidity
score19 and its components (acute myocardial infarction, peripheral vascular disease, stroke,
dementia, chronic obstructive pulmonary disease, rheumatologic disease, ulcer, paralysis,
renal disease, AIDS, diabetes, liver disease, and cancer). Romano score was dichotomized
around the median value (high Romano score is greater than 3).
Laboratory Methods and Molecular Typing
All strains were shipped to Imperial College London in the United Kingdom and stored at
−80°C for staphylococcal protein A (spa) typing; spa typing was performed on all isolates
and analyzed as described previously.20 Isolates with spa type t008 were considered CA-
MRSA. Multilocus sequence typing (MLST) and PFGE were performed on a randomly
sampled subset of the isolates (n = 288) to confirm spa assignments for MRSA strain types,
according to methods described previously.21 We randomly selected 1 isolate per hospital
for the 10 most common spa types and 1 isolate per remaining spa types.
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We calculated both the prevalence of MRSA and CA-MRSA per 10,000 admissions and the
percentage of isolates corresponding to CA-MRSA from each hospital. We determined how
often CA-MRSA and HA-MRSA strains were CO versus HO. We tested the association of
hospital-level characteristics described above with individual carriage of CA-MRSA.
Variables with P < .1 from bivariate models entered a multivariate individual-level
generalized estimating equation (GEE) model, clustered by hospital, and were retained at α
= 0.05. We repeated our analyses, stratifying by HO versus CO of infection.
RESULTS
Facility characteristics are listed in Table 1. We collected 2,246 isolates from 30 hospitals
during the time period October 2008 to April 2010; a median of 74 isolates were collected
from each hospital (range, 4–143). Thirteen hospitals reached the goal of 100 collected
isolates within 12 months (median period, 9 months (range, 6–11.5 months); the remaining
smaller hospitals collected a median of 38 isolates (range, 4–91 isolates). The median
prevalence of total MRSA and CA-MRSA across OC hospitals were 106 isolates per 10,000
admissions (range, 35–571) and 50 isolates per 10,000 admissions (range, 14–178),
respectively. Overall, 46% of isolates (1,033 of 2,246) were spa type t008 (CA-MRSA). The
median percentage of CA-MRSA isolates per hospital was 46% (range 14%–81%; Figure 1).
The 2 other most common spa types were t002, which comprised 15% of isolates (347 of
2,246), and t242, which comprised 21% of isolates (478 of 2,246). Among isolates with spa
type t008, all 32 isolates tested by PFGE were USA300. Both t002 and t242 spa types
correspond to USA100. Among CA-MRSA isolates, 66% were isolated from wounds (668
of 1,019 with data on specimen source), 14% from the respiratory system (144 of 1,019;
sputum, bronchial lavage, and tracheal aspirate), 9% from other sources (93 of 1,019), 8%
from blood (81 of 1,019), and 3% from urine (33 of 1,019). Of HA-MRSA isolates, there
were 26% from wounds (214 of 824), 39% from respiratory sources (324 of 824), 10% from
other sources (83 of 824), 9% from blood (77 of 824), and 15% from urine (125 of 824).
CA-MRSA was the most common source of community-onset isolates (51%; 751 of 1,485)
but also represented more than a third of hospital-onset isolates (37%; 282 of 761; Table 2).
In bivariate tests (Table 3), CA-MRSA isolation was associated (P < .1) with the following
hospital characteristics: lower annual admissions, pediatric hospitals, proprietary (for profit)
hospitals, and a higher percentage of patients with non-White race, Hispanic ethnicity,
Medicaid insurance, acute myocardial infarction, congestive heart failure, peripheral
vascular disease, stroke, chronic obstructive pulmonary disease, rheumatologic disease,
peptic ulcer, renal disease, AIDS, cancer, and high Romano score. CA-MRSA carriage was
not associated with long-term acute care facilities or the percentage of patients with male
sex, diabetes, dementia, paralysis, liver disease, or surgery during the current admission.
Results for continuous variables are expressed per 10% increase. For hospital-onset isolates
only, annual admissions and proprietary hospitals were not significant. For community-onset
isolates only, male sex was significantly associated, whereas the percentage of patients with
acute myocardial infarction, congestive heart failure, chronic obstructive pulmonary disease,
peptic ulcer, or renal disease were not.
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In multivariate models (Table 4), CA-MRSA isolation was associated with smaller hospitals
(odds ratio [OR], 0.97, or 3% decreased odds of CA-MRSA isolation per 1,000 annual
admissions; P < .001), hospitals with more Medicaid-insured patients (OR, 1.2, or 20%
increase in odds of CA-MRSA isolation per 10% increase in Medicaid-insured patients; P
= .002), and those with a high proportion of patients with a low Romano comorbidity score
(OR, 1.3, or 30% increase in odds of CA-MRSA isolation per 10% increase in patients with
low score; P < .001). The Romano score was a stronger predictor of CA-MRSA isolation
than any individual component. Results were similar when restricted to hospital-onset
isolates only.
DISCUSSION
We found that nearly half of MRSA isolates collected in a single county were CA-MRSA.
CA-MRSA was also the dominant strain in 9 of the 30 hospitals. There was substantial
variation in CA-MRSA prevalence across hospitals, from less than one-fifth to over three-
fourths of collected strains. Notably, our participating facilities included a range of
community hospitals, academic centers, long-term care facilities, and dedicated pediatric
hospitals.
CA-MRSA isolation was associated with several hospital-level characteristics, including
smaller size. This finding may be explained by smaller hospitals being more likely to admit
patients directly from the community, whereas larger hospitals are often academic or referral
centers that receive patients transferred for a higher level of care.22 Penetration of CA-
MRSA into the healthcare system may thus begin with these smaller community hospitals
and then spread to larger centers as patients are referred for tertiary care. CA-MRSA
isolation was also associated with hospitals serving patients with lower comorbidity scores,
which is consistent with the admission of patients directly from the community who may be
relatively healthy compared with those from hospitals. Finally, CA-MRSA was associated
with hospitals with more patients insured by Medicaid. This may indicate that CA-MRSA
carriage is linked to lower socioeconomic status, which has been found in earlier studies and
may be the result of crowded living environments and fewer opportunities for personal
hygiene.23,24 All multivariate model results remained significant when we included only HO
isolates. Thus, smaller community hospitals, which serve patients who are generally
healthier, may be initial points of entry into the healthcare system for CA-MRSA.
Understanding which hospitals are at risk for high CA-MRSA burden may facilitate targeted
interventions.
CA-MRSA penetration into hospitals may require new infection control strategies. There is
some evidence that CA-MRSA strains, particularly USA300, may cause more severe disease
than other strains in the hospital setting, including necrotizing fasciitis and pneumonia.10
CA-MRSA strains may also be more transmissible than other strains because of their higher
growth rate and enhanced fitness, which may lead to a higher overall MRSA burden.11-15
Earlier studies have demonstrated that nasal colonization with CA-MRSA is not a necessary
precursor for infection,4 which suggests that nasal decolonization efforts may have a limited
effect on preventing infection or transmission. In addition, community-based transmission of
CA-MRSA commonly occurs via direct skin-to-skin contact.4,25 This direct transmission
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may simply be more relevant in the community setting, where skin-to-skin contact as a
result of sports or family interaction is more likely to occur, than among hospital inpatients.
Alternately, it may reflect the greater propensity of CA-MRSA to inhabit or infect the skin
compared with HA-MRSA.1-3,25 Environmental contamination has also been identified as a
major route of CA-MRSA transmission,4,26-28 particularly among household contacts.29
Although environmental contamination has been shown to increase the risk of HA-MRSA in
acute care settings as well,30-32 this transmission route may be more important for CA-
MRSA. In particular, extranasal colonization with CA-MRSA is common, especially in the
axilla, groin, and rectum,4 which may result in greater shedding and environmental
contamination. Strategies to reduce CA-MRSA burden may also need to target community
sources or focus on high-risk facilities.
This study has several limitations. We did not account for variable culturing practices
among hospitals or physicians, which may impact the number or type of MRSA isolates
collected. Our collection did not include screening cultures and thus did not capture the large
number of patients who carry MRSA in the nares. However, California did not begin
mandatory admission screening for MRSA until 2009 (midway through our strain collection
period), and thus inclusion of screening cultures would have resulted in disproportionate
numbers of MRSA isolates from hospitals where screening had already begun. We did not
analyze individual-level characteristics, but our goal was to identify hospital-level
characteristics associated with CA-MRSA isolation. Because infection control practices are
usually implemented at the hospital level, identifying hospitals that are at risk for CA-
MRSA may be helpful for future interventions by infection control programs.
We found that CA-MRSA burden was substantial in a large California county and varied
considerably across hospitals. CA-MRSA appears to be widely endemic in hospitals, and
USA300 and other strains may be more transmissible or cause more severe disease than HA-
MRSA strains. Reducing CA-MRSA burden in hospitals may require additional infection
control interventions targeted at high-risk facilities.
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Percentage of all isolates that were community-associated methicillin-resistant
Staphylococcus aureus (CA-MRSA; gray) and percentage of isolates that were CA-MRSA
and associated with hospital-onset infection (black), by hospital. Hospitals that collected
fewer than 50 isolates are marked with a star; fewer than 20 isolates were collected from
hospitals 3, 4, 6, 7, and 30.
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TABLE 1











Annual no. of admissions, median (range) 6,920 (70–33,080) 11,140 (943–33,080) 2,178 (70–12,496) 592 (70–1,162)
Length of stay, median days (range) 3 (2–64) 3 (2–4) 2 (2–64) 24 (11–64)
Hospital demographic characteristic
 Age, years
  <18 1 (0–99) <1 (0–100) 97 (93–99) 0 (0–93)
  18–34b 16 (1–38) 17 (7–38) 3 (<31 to 7) 1 (1–2)
  35–49 18 (6–41) 18 (12–22) NA 41 (6–41)
  50–64 20 (13–33) 20 (15–29) NA 18 (13–33)
  65–84 34 (7–59) 32 (20–42) NA 54 (7–59)
  ≥85 15 (0–24) 14 (5–23) NA 23 (0–24)
  Male sex 43 (33–64) 41 (33–59) 59 (54–64) 53 (41–64)
 Race
  White 86 (53–96) 86 (53–96) 57 (23–57) 79 (73–80)
  Black 2 (1–7) 2 (1–7) 2 (2–7) 4 (1–7)
  Asian 14 (0–42) 15 (0–42) 6 (0–8) 13 (0–15)
  Native American 0 (0–1) 0 (0–1) 0 0 (0–1)
  Other or unknown 11 (1–14) 10 (1–11) 3 (1–14) 12 (5–14)
  Hispanic ethnicity 18 (3–65) 19 (3–65) 28 (21–65) 10 (4–21)
 Insurance carrier
  Medicare insurance 45 (26–82) 41 (26–61) NA 82 (71–94)
  Medicaid insurance 13 (2–73) 15 (2–73) 39 (14–73) 4 (2–14)
  Private insurance 27 (0–94) 28 (3–56) 56 (25–86) 15 (1–86)
Hospital case mix
 Acute myocardial infarction 9 (0–17) 9 (0–13) 0 (0) 12 (0–17)
 Congestive heart failure 16 (0–43) 16 (0–26) 0 (0–2) 36 (0–43)
 Peripheral vascular disease 6 (0–18) 6 (0–9) 0 (0) 16 (0–18)
 Stroke 10 (1–36) 9 (1–14) 2 (1–36) 20 (17–36)
 Dementia 3 (0–22) 3 (0–10) 0 (0) 11 (0–22)
 COPD/asthma 18 (0–47) 18 (14–27) 15 (0–15) 35 (0–47)
 Rheumatologic disease 2 (0–7) 2 (0–5) 0 (0) 4 (0–7)
 Ulcer 2 (0–4) 3 (0–5) 0 (0) 2 (0–4)
 Paralysis 2 (0–36) 2 (0–6) 2 (0–36) 6 (5–36)
 Renal disease 12 (0–34) 12 (0–17) 0 (0–1) 29 (0–34)
 AIDS 0 (0–3) 0 (0–3) 0 (0) 0 (0–1)
 Diabetes 23 (0–43) 23 (1–34) 0.7 (0–1.8) 43 (0–48)
 Liver disease 3 (0–7) 3 (0–7) 0.4 (0–0.5) 3 (0–5)
 Cancer 7 (0–17) 7 (0–17) 0.2 (0–6) 10 (0–12)
 Current surgery 25 (0–47) 28 (8–47) 20 (0–24) 4 (0–10)
























 High Romano scorec 26 (0–66) 26 (0–38) <1 (0–3) 58 (0–66)
NOTE. Data are median % of all hospitalized patients (range), unless otherwise indicated. COPD, chronic obstructive pulmonarydisease; LTAC,
long-term acute care; NA, not applicable.
aOne hospital is both a pediatric hospital and an LTAC facility.
b
Median and range values for ages over 18 years and Medicare insurance do not include dedicated pediatric hospitals.
c
Romano score was dichotomized into high (≥3) versus low scores.
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TABLE 2
Distribution of Community-Associated (CA) versus Healthcare-Associated(HA) Methicillin-Resistant
Staphylococcus aureus(MRSA) Strain Types from 30 Hospitals, by Isolate Collection Date
Variable
No. (%) of community-
onset infection isolates
No. (%) of hospital-
onset infection isolates
All sources Blood only All sources Blood only
CA-MRSA
 t008 spa type 751 (51) 62 (39) 282 (37) 19 (37)
 Other CA-MRSA spa typesa 114 (8) 20 (12) 47 (6) 4 (8)
 All CA-MRSA spa types 865 (58) 82 (51) 329 (43) 23 (44)
HA-MRSA
 t002 spa types 192 (13) 22 (14) 155 (20) 8 (15)
 t242 spa types 293 (20) 36 (22) 185 (24) 11 (21)
 Other HA-MRSA spa types 83 (6) 12 (7) 71 (9) 7 (13)
 All HA-MRSA spa types 568 (38) 70 (44) 411 (54) 26 (50)
Other strainsb 39 (4) 7 (5) 19 (3) 3 (6)
NOTE. Community-onset infection isolates were defined as those isolated on or before the second day of hospitalization, and hospital-onset
infection isolates were defined as those isolated after the second day of hospitalization.
a
For CA-MRSA, other spa types were also multilocus sequence type ST8; for HA-MRSA,these other spa types were also multilocus sequence type
ST5.
b
These strains were not related to ST5 or ST8.
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TABLE 3
Bivariate Analysis of Hospital Characteristics Associated with Community-Associated Methicillin-Resistant






Hospital characteristic OR P OR P OR P
Annual admissions (per 1,000 admissions) 0.9 .03 0.9 .5 0.9 <.001
Long-term acute care facility 0.6 .4 0.4 <.001 - -
Pediatric hospital 3.2 <.001 5.2 .001 2.6 <.001
Nonprofit hospital 0.6 .04 0.7 .2 0.6 .03
Demographic characteristic, % of all patients in that hospital
 Male sex 1.3 .3 1.2 .5 1.4 .06
 Non-White race 1.2 <.001 1.2 <.001 1.2 <.001
 Hispanic ethnicity 1.3 <.001 1.2 .01 1.2 <.001
 Medicaid insurance 1.3 <.001 1.4 <.001 1.2 <.001
Case mix, % of all patients in that hospital
 Acute myocardial infarction 0.5 .06 0.3 .002 0.7 .4
 Congestive heart failure 0.7 .004 0.6 .001 0.8 .2
 Peripheral vascular disease 0.2 <.001 0.3 <.001 0.3 .002
 Stroke 0.4 .001 0.4 .005 0.5 .08
 Dementia 0.6 .3 0.5 .2 0.9 .9
 COPD/asthma 0.7 <.001 0.7 <.001 0.6 .1
 Rheumatologic disease 0.0 <.001 0.0 <.001 0.0 <.001
 Peptic ulcer 0.2 .08 0.0 .04 0.4 .3
 Paralysis 0.5 .3 0.5 .3 1.4 .8
 Renal disease 0.6 .002 0.6 .002 0.6 .1
 AIDS 0.1 .1 0.0 .08 0.2 .2
 Diabetes 0.9 .4 0.8 .07 1.1 .7
 Liver disease 0.5 .6 0.2 .2 0.9 .9
 Cancer 0.4 .004 0.4 .007 0.4 .008
 Current surgery 0.9 .7 0.9 .8 0.8 .1
 High Romano score 0.7 <.001 0.7 <.001 0.7 .01
NOTE. Community-onset infection isolates were defined as those isolated on or before the second day of hospitalization, and hospital-onset
infection isolates were defined as those isolated after the second day of hospitalization. The following variables are continuous and expressed per
10% increase: the percentage of patients with male sex, non-White race, Hispanic ethnicity, Medicaid insurance, current surgery, high Romano
score, or any of the listed comorbidities. COPD, chronic obstructive pulmonary disease; OR, odds ratio.
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TABLE 4
Multivariate Generalized Estimating Equations Model Analysis of Hospital






Hospital characteristic OR (95% CI) P OR (95% CI) P OR (95% CI) P
Annual admissions (per 1,000 patients) 0.97 (0.96–0.98) <001 0.98 (0.96–1.0) .045 0.97 (0.95–0.98) <001
Percentage Medicaid insured patients 1.2 (1.1–1.3) .002 1.2 (1.1–1.4) .002 1.2 (1.1–1.3) .001
Percentage patients with low Romano scorea 1.3 (1.1–1.5) <001 1.3 (1.1–1.6) .004 1.1 (0.9–1.4) .5
NOTE. CI, confidence interval; OR, odds ratio.
a
Romano score ranges from 0 to 6; a score less than 3 was considered low.
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